Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Arcus Biosciences (RCUS) Tops Q3 EPS by 2c

November 6, 2024 5:11 PM EST

Arcus Biosciences (NYSE: RCUS) reported Q3 EPS of ($1.00), $0.02 better than the analyst estimate of ($1.02). Revenue for the quarter came in at $48 million versus the consensus estimate of $38.95 million.

For earnings history and earnings-related data on Arcus Biosciences (RCUS) click here.

... More